nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—HTR2B—cardial valve—systemic scleroderma	0.0515	0.198	CbGeAlD
Asenapine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0414	0.32	CbGbCtD
Asenapine—CYP1A2—Leflunomide—systemic scleroderma	0.0395	0.305	CbGbCtD
Asenapine—CYP2D6—Captopril—systemic scleroderma	0.0255	0.197	CbGbCtD
Asenapine—HTR7—myenteric nerve plexus—systemic scleroderma	0.0252	0.0968	CbGeAlD
Asenapine—HTR7—pulmonary artery—systemic scleroderma	0.0179	0.0686	CbGeAlD
Asenapine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0157	0.0604	CbGeAlD
Asenapine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0128	0.0988	CbGbCtD
Asenapine—HTR2A—pulmonary artery—systemic scleroderma	0.0111	0.0428	CbGeAlD
Asenapine—CYP3A4—Prednisone—systemic scleroderma	0.0102	0.079	CbGbCtD
Asenapine—HTR1B—artery—systemic scleroderma	0.00859	0.033	CbGeAlD
Asenapine—HTR1D—artery—systemic scleroderma	0.00831	0.0319	CbGeAlD
Asenapine—HTR1B—blood vessel—systemic scleroderma	0.00669	0.0257	CbGeAlD
Asenapine—HTR7—artery—systemic scleroderma	0.00662	0.0254	CbGeAlD
Asenapine—HTR1D—blood vessel—systemic scleroderma	0.00648	0.0249	CbGeAlD
Asenapine—UGT1A4—digestive system—systemic scleroderma	0.00599	0.023	CbGeAlD
Asenapine—HTR7—endothelium—systemic scleroderma	0.00559	0.0215	CbGeAlD
Asenapine—HTR7—blood vessel—systemic scleroderma	0.00516	0.0198	CbGeAlD
Asenapine—HRH2—skin of body—systemic scleroderma	0.0047	0.018	CbGeAlD
Asenapine—HTR2A—artery—systemic scleroderma	0.00413	0.0159	CbGeAlD
Asenapine—HRH2—digestive system—systemic scleroderma	0.00376	0.0144	CbGeAlD
Asenapine—HTR2A—endothelium—systemic scleroderma	0.00349	0.0134	CbGeAlD
Asenapine—HTR1D—connective tissue—systemic scleroderma	0.00332	0.0127	CbGeAlD
Asenapine—ADRB1—connective tissue—systemic scleroderma	0.00323	0.0124	CbGeAlD
Asenapine—HTR2A—blood vessel—systemic scleroderma	0.00322	0.0123	CbGeAlD
Asenapine—HRH2—lung—systemic scleroderma	0.00314	0.012	CbGeAlD
Asenapine—HTR2B—smooth muscle tissue—systemic scleroderma	0.00283	0.0108	CbGeAlD
Asenapine—HTR2B—skin of body—systemic scleroderma	0.00279	0.0107	CbGeAlD
Asenapine—HTR7—connective tissue—systemic scleroderma	0.00264	0.0102	CbGeAlD
Asenapine—HTR7—smooth muscle tissue—systemic scleroderma	0.00242	0.00929	CbGeAlD
Asenapine—SLC6A4—digestive system—systemic scleroderma	0.00225	0.00864	CbGeAlD
Asenapine—HTR2B—digestive system—systemic scleroderma	0.00223	0.00856	CbGeAlD
Asenapine—HTR2B—tendon—systemic scleroderma	0.00212	0.00815	CbGeAlD
Asenapine—HRH1—connective tissue—systemic scleroderma	0.00197	0.00758	CbGeAlD
Asenapine—ADRB1—lung—systemic scleroderma	0.00195	0.00747	CbGeAlD
Asenapine—ADRA2A—connective tissue—systemic scleroderma	0.00194	0.00745	CbGeAlD
Asenapine—HTR7—digestive system—systemic scleroderma	0.00191	0.00733	CbGeAlD
Asenapine—SLC6A4—lung—systemic scleroderma	0.00188	0.00722	CbGeAlD
Asenapine—HTR2B—lung—systemic scleroderma	0.00186	0.00715	CbGeAlD
Asenapine—HTR7—tendon—systemic scleroderma	0.00182	0.00698	CbGeAlD
Asenapine—HRH1—smooth muscle tissue—systemic scleroderma	0.00181	0.00693	CbGeAlD
Asenapine—ADRA2C—tendon—systemic scleroderma	0.00167	0.00641	CbGeAlD
Asenapine—HTR2A—connective tissue—systemic scleroderma	0.00165	0.00633	CbGeAlD
Asenapine—HTR7—lung—systemic scleroderma	0.0016	0.00612	CbGeAlD
Asenapine—CYP1A2—digestive system—systemic scleroderma	0.00152	0.00585	CbGeAlD
Asenapine—HTR2A—smooth muscle tissue—systemic scleroderma	0.00151	0.00579	CbGeAlD
Asenapine—DRD2—lung—systemic scleroderma	0.00151	0.00579	CbGeAlD
Asenapine—ADRA2C—lung—systemic scleroderma	0.00147	0.00563	CbGeAlD
Asenapine—HRH1—digestive system—systemic scleroderma	0.00143	0.00548	CbGeAlD
Asenapine—HRH1—tendon—systemic scleroderma	0.00136	0.00521	CbGeAlD
Asenapine—ADRA2A—tendon—systemic scleroderma	0.00133	0.00512	CbGeAlD
Asenapine—CYP1A2—lung—systemic scleroderma	0.00127	0.00488	CbGeAlD
Asenapine—HTR2A—digestive system—systemic scleroderma	0.00119	0.00457	CbGeAlD
Asenapine—HRH1—lung—systemic scleroderma	0.00119	0.00457	CbGeAlD
Asenapine—ADRA2A—lung—systemic scleroderma	0.00117	0.00449	CbGeAlD
Asenapine—Gynaecomastia—Methotrexate—systemic scleroderma	0.00114	0.00187	CcSEcCtD
Asenapine—Dyspepsia—Captopril—systemic scleroderma	0.00114	0.00187	CcSEcCtD
Asenapine—HTR2A—tendon—systemic scleroderma	0.00113	0.00435	CbGeAlD
Asenapine—Mental disorder—Lisinopril—systemic scleroderma	0.00113	0.00185	CcSEcCtD
Asenapine—Dizziness—Pentoxifylline—systemic scleroderma	0.00113	0.00185	CcSEcCtD
Asenapine—Hypertension—Leflunomide—systemic scleroderma	0.00113	0.00185	CcSEcCtD
Asenapine—Malaise—Mycophenolic acid—systemic scleroderma	0.00112	0.00184	CcSEcCtD
Asenapine—Malnutrition—Lisinopril—systemic scleroderma	0.00112	0.00184	CcSEcCtD
Asenapine—Syncope—Mycophenolic acid—systemic scleroderma	0.00112	0.00183	CcSEcCtD
Asenapine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00112	0.00183	CcSEcCtD
Asenapine—Fatigue—Captopril—systemic scleroderma	0.00112	0.00183	CcSEcCtD
Asenapine—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00182	CcSEcCtD
Asenapine—Arthralgia—Leflunomide—systemic scleroderma	0.00111	0.00182	CcSEcCtD
Asenapine—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00182	CcSEcCtD
Asenapine—Anxiety—Leflunomide—systemic scleroderma	0.00111	0.00182	CcSEcCtD
Asenapine—Osteoarthritis—Prednisone—systemic scleroderma	0.00111	0.00181	CcSEcCtD
Asenapine—Constipation—Captopril—systemic scleroderma	0.00111	0.00181	CcSEcCtD
Asenapine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00111	0.00181	CcSEcCtD
Asenapine—CYP3A4—digestive system—systemic scleroderma	0.0011	0.00423	CbGeAlD
Asenapine—Dysgeusia—Lisinopril—systemic scleroderma	0.0011	0.0018	CcSEcCtD
Asenapine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.0011	0.0018	CcSEcCtD
Asenapine—Dry mouth—Leflunomide—systemic scleroderma	0.00109	0.00178	CcSEcCtD
Asenapine—Vomiting—Pentoxifylline—systemic scleroderma	0.00109	0.00178	CcSEcCtD
Asenapine—CYP2D6—digestive system—systemic scleroderma	0.00109	0.00417	CbGeAlD
Asenapine—Psychotic disorder—Prednisone—systemic scleroderma	0.00108	0.00177	CcSEcCtD
Asenapine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00108	0.00177	CcSEcCtD
Asenapine—Muscle spasms—Lisinopril—systemic scleroderma	0.00108	0.00177	CcSEcCtD
Asenapine—Rash—Pentoxifylline—systemic scleroderma	0.00108	0.00176	CcSEcCtD
Asenapine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00108	0.00176	CcSEcCtD
Asenapine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00108	0.00176	CcSEcCtD
Asenapine—Headache—Pentoxifylline—systemic scleroderma	0.00107	0.00175	CcSEcCtD
Asenapine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00107	0.00175	CcSEcCtD
Asenapine—Diabetes mellitus—Methotrexate—systemic scleroderma	0.00106	0.00174	CcSEcCtD
Asenapine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00106	0.00174	CcSEcCtD
Asenapine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00106	0.00173	CcSEcCtD
Asenapine—Asthenia—Mometasone—systemic scleroderma	0.00106	0.00173	CcSEcCtD
Asenapine—Irritability—Prednisone—systemic scleroderma	0.00106	0.00173	CcSEcCtD
Asenapine—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00173	CcSEcCtD
Asenapine—Hypotension—Azathioprine—systemic scleroderma	0.00105	0.00173	CcSEcCtD
Asenapine—Tremor—Lisinopril—systemic scleroderma	0.00105	0.00172	CcSEcCtD
Asenapine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00172	CcSEcCtD
Asenapine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00105	0.00171	CcSEcCtD
Asenapine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00104	0.00171	CcSEcCtD
Asenapine—Tachycardia—Leflunomide—systemic scleroderma	0.00104	0.00171	CcSEcCtD
Asenapine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00104	0.0017	CcSEcCtD
Asenapine—Anaemia—Lisinopril—systemic scleroderma	0.00104	0.0017	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00103	0.00169	CcSEcCtD
Asenapine—Angioedema—Lisinopril—systemic scleroderma	0.00103	0.00168	CcSEcCtD
Asenapine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00168	CcSEcCtD
Asenapine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00167	CcSEcCtD
Asenapine—Nausea—Pentoxifylline—systemic scleroderma	0.00101	0.00166	CcSEcCtD
Asenapine—Malaise—Lisinopril—systemic scleroderma	0.00101	0.00166	CcSEcCtD
Asenapine—Syncope—Lisinopril—systemic scleroderma	0.00101	0.00165	CcSEcCtD
Asenapine—Leukopenia—Lisinopril—systemic scleroderma	0.001	0.00165	CcSEcCtD
Asenapine—Shock—Mycophenolic acid—systemic scleroderma	0.001	0.00164	CcSEcCtD
Asenapine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000997	0.00163	CcSEcCtD
Asenapine—Hypotension—Leflunomide—systemic scleroderma	0.000996	0.00163	CcSEcCtD
Asenapine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000996	0.00163	CcSEcCtD
Asenapine—HTR2A—lung—systemic scleroderma	0.000995	0.00382	CbGeAlD
Asenapine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000993	0.00163	CcSEcCtD
Asenapine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00099	0.00162	CcSEcCtD
Asenapine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000987	0.00162	CcSEcCtD
Asenapine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000984	0.00161	CcSEcCtD
Asenapine—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000976	0.0016	CcSEcCtD
Asenapine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000975	0.0016	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000971	0.00159	CcSEcCtD
Asenapine—Insomnia—Leflunomide—systemic scleroderma	0.000964	0.00158	CcSEcCtD
Asenapine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000963	0.00158	CcSEcCtD
Asenapine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000956	0.00157	CcSEcCtD
Asenapine—Arthralgia—Lisinopril—systemic scleroderma	0.000956	0.00157	CcSEcCtD
Asenapine—Anxiety—Lisinopril—systemic scleroderma	0.000952	0.00156	CcSEcCtD
Asenapine—Dyspnoea—Leflunomide—systemic scleroderma	0.000951	0.00156	CcSEcCtD
Asenapine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00095	0.00156	CcSEcCtD
Asenapine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000946	0.00155	CcSEcCtD
Asenapine—Dyspepsia—Leflunomide—systemic scleroderma	0.000939	0.00154	CcSEcCtD
Asenapine—Vomiting—Mometasone—systemic scleroderma	0.000936	0.00153	CcSEcCtD
Asenapine—Dry mouth—Lisinopril—systemic scleroderma	0.000935	0.00153	CcSEcCtD
Asenapine—Rash—Mometasone—systemic scleroderma	0.000929	0.00152	CcSEcCtD
Asenapine—Asthenia—Captopril—systemic scleroderma	0.000928	0.00152	CcSEcCtD
Asenapine—Dermatitis—Mometasone—systemic scleroderma	0.000928	0.00152	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000927	0.00152	CcSEcCtD
Asenapine—Osteoarthritis—Methotrexate—systemic scleroderma	0.000925	0.00152	CcSEcCtD
Asenapine—Headache—Mometasone—systemic scleroderma	0.000923	0.00151	CcSEcCtD
Asenapine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000921	0.00151	CcSEcCtD
Asenapine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00092	0.00151	CcSEcCtD
Asenapine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00092	0.00151	CcSEcCtD
Asenapine—Fatigue—Leflunomide—systemic scleroderma	0.000919	0.00151	CcSEcCtD
Asenapine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000916	0.0015	CcSEcCtD
Asenapine—Constipation—Leflunomide—systemic scleroderma	0.000912	0.00149	CcSEcCtD
Asenapine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000909	0.00149	CcSEcCtD
Asenapine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000907	0.00149	CcSEcCtD
Asenapine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000904	0.00148	CcSEcCtD
Asenapine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000904	0.00148	CcSEcCtD
Asenapine—Shock—Lisinopril—systemic scleroderma	0.000901	0.00148	CcSEcCtD
Asenapine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000899	0.00147	CcSEcCtD
Asenapine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000897	0.00147	CcSEcCtD
Asenapine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000895	0.00147	CcSEcCtD
Asenapine—Neutropenia—Prednisone—systemic scleroderma	0.000895	0.00147	CcSEcCtD
Asenapine—Tachycardia—Lisinopril—systemic scleroderma	0.000894	0.00147	CcSEcCtD
Asenapine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000887	0.00145	CcSEcCtD
Asenapine—Irritability—Methotrexate—systemic scleroderma	0.000883	0.00145	CcSEcCtD
Asenapine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000882	0.00145	CcSEcCtD
Asenapine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00088	0.00144	CcSEcCtD
Asenapine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000878	0.00144	CcSEcCtD
Asenapine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000877	0.00144	CcSEcCtD
Asenapine—Nausea—Mometasone—systemic scleroderma	0.000875	0.00143	CcSEcCtD
Asenapine—Weight increased—Prednisone—systemic scleroderma	0.000871	0.00143	CcSEcCtD
Asenapine—Constipation—Mycophenolic acid—systemic scleroderma	0.00087	0.00143	CcSEcCtD
Asenapine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000864	0.00142	CcSEcCtD
Asenapine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000863	0.00141	CcSEcCtD
Asenapine—Hypotension—Lisinopril—systemic scleroderma	0.000856	0.0014	CcSEcCtD
Asenapine—Dizziness—Captopril—systemic scleroderma	0.000855	0.0014	CcSEcCtD
Asenapine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000852	0.0014	CcSEcCtD
Asenapine—Depression—Prednisone—systemic scleroderma	0.000851	0.00139	CcSEcCtD
Asenapine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000849	0.00139	CcSEcCtD
Asenapine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000837	0.00137	CcSEcCtD
Asenapine—Breast disorder—Methotrexate—systemic scleroderma	0.000836	0.00137	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000835	0.00137	CcSEcCtD
Asenapine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000834	0.00137	CcSEcCtD
Asenapine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000832	0.00136	CcSEcCtD
Asenapine—Insomnia—Lisinopril—systemic scleroderma	0.000829	0.00136	CcSEcCtD
Asenapine—Vomiting—Captopril—systemic scleroderma	0.000823	0.00135	CcSEcCtD
Asenapine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000819	0.00134	CcSEcCtD
Asenapine—Dyspnoea—Lisinopril—systemic scleroderma	0.000817	0.00134	CcSEcCtD
Asenapine—Rash—Captopril—systemic scleroderma	0.000816	0.00134	CcSEcCtD
Asenapine—Dermatitis—Captopril—systemic scleroderma	0.000815	0.00134	CcSEcCtD
Asenapine—Somnolence—Lisinopril—systemic scleroderma	0.000814	0.00133	CcSEcCtD
Asenapine—Headache—Captopril—systemic scleroderma	0.00081	0.00133	CcSEcCtD
Asenapine—Dyspepsia—Lisinopril—systemic scleroderma	0.000806	0.00132	CcSEcCtD
Asenapine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000803	0.00132	CcSEcCtD
Asenapine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000791	0.0013	CcSEcCtD
Asenapine—Fatigue—Lisinopril—systemic scleroderma	0.00079	0.00129	CcSEcCtD
Asenapine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00079	0.00129	CcSEcCtD
Asenapine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000787	0.00129	CcSEcCtD
Asenapine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000786	0.00129	CcSEcCtD
Asenapine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000786	0.00129	CcSEcCtD
Asenapine—Constipation—Lisinopril—systemic scleroderma	0.000783	0.00128	CcSEcCtD
Asenapine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000783	0.00128	CcSEcCtD
Asenapine—Nausea—Captopril—systemic scleroderma	0.000768	0.00126	CcSEcCtD
Asenapine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000767	0.00126	CcSEcCtD
Asenapine—Asthenia—Leflunomide—systemic scleroderma	0.000765	0.00125	CcSEcCtD
Asenapine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000753	0.00123	CcSEcCtD
Asenapine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00075	0.00123	CcSEcCtD
Asenapine—Neutropenia—Methotrexate—systemic scleroderma	0.000748	0.00123	CcSEcCtD
Asenapine—Dizziness—Azathioprine—systemic scleroderma	0.000747	0.00122	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000731	0.0012	CcSEcCtD
Asenapine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00073	0.0012	CcSEcCtD
Asenapine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000726	0.00119	CcSEcCtD
Asenapine—Vomiting—Azathioprine—systemic scleroderma	0.000718	0.00118	CcSEcCtD
Asenapine—Eye disorder—Prednisone—systemic scleroderma	0.000716	0.00117	CcSEcCtD
Asenapine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000716	0.00117	CcSEcCtD
Asenapine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000714	0.00117	CcSEcCtD
Asenapine—Rash—Azathioprine—systemic scleroderma	0.000712	0.00117	CcSEcCtD
Asenapine—Dermatitis—Azathioprine—systemic scleroderma	0.000711	0.00117	CcSEcCtD
Asenapine—Depression—Methotrexate—systemic scleroderma	0.000711	0.00117	CcSEcCtD
Asenapine—Headache—Azathioprine—systemic scleroderma	0.000707	0.00116	CcSEcCtD
Asenapine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000707	0.00116	CcSEcCtD
Asenapine—Dizziness—Leflunomide—systemic scleroderma	0.000705	0.00116	CcSEcCtD
Asenapine—Stomatitis—Methotrexate—systemic scleroderma	0.000695	0.00114	CcSEcCtD
Asenapine—Angiopathy—Prednisone—systemic scleroderma	0.000695	0.00114	CcSEcCtD
Asenapine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000693	0.00114	CcSEcCtD
Asenapine—Immune system disorder—Prednisone—systemic scleroderma	0.000692	0.00113	CcSEcCtD
Asenapine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000686	0.00112	CcSEcCtD
Asenapine—Vomiting—Leflunomide—systemic scleroderma	0.000678	0.00111	CcSEcCtD
Asenapine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000675	0.00111	CcSEcCtD
Asenapine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000674	0.00111	CcSEcCtD
Asenapine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000673	0.0011	CcSEcCtD
Asenapine—Rash—Leflunomide—systemic scleroderma	0.000672	0.0011	CcSEcCtD
Asenapine—Dermatitis—Leflunomide—systemic scleroderma	0.000672	0.0011	CcSEcCtD
Asenapine—Mental disorder—Prednisone—systemic scleroderma	0.000671	0.0011	CcSEcCtD
Asenapine—Nausea—Azathioprine—systemic scleroderma	0.000671	0.0011	CcSEcCtD
Asenapine—Headache—Leflunomide—systemic scleroderma	0.000668	0.00109	CcSEcCtD
Asenapine—Malnutrition—Prednisone—systemic scleroderma	0.000667	0.00109	CcSEcCtD
Asenapine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000665	0.00109	CcSEcCtD
Asenapine—Asthenia—Lisinopril—systemic scleroderma	0.000657	0.00108	CcSEcCtD
Asenapine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000647	0.00106	CcSEcCtD
Asenapine—Rash—Mycophenolic acid—systemic scleroderma	0.000641	0.00105	CcSEcCtD
Asenapine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000641	0.00105	CcSEcCtD
Asenapine—Headache—Mycophenolic acid—systemic scleroderma	0.000637	0.00104	CcSEcCtD
Asenapine—Nausea—Leflunomide—systemic scleroderma	0.000633	0.00104	CcSEcCtD
Asenapine—Anaemia—Prednisone—systemic scleroderma	0.000616	0.00101	CcSEcCtD
Asenapine—Agitation—Prednisone—systemic scleroderma	0.000613	0.001	CcSEcCtD
Asenapine—Angioedema—Prednisone—systemic scleroderma	0.000609	0.000998	CcSEcCtD
Asenapine—Dizziness—Lisinopril—systemic scleroderma	0.000606	0.000993	CcSEcCtD
Asenapine—Nausea—Mycophenolic acid—systemic scleroderma	0.000604	0.00099	CcSEcCtD
Asenapine—Malaise—Prednisone—systemic scleroderma	0.000601	0.000985	CcSEcCtD
Asenapine—Eye disorder—Methotrexate—systemic scleroderma	0.000598	0.00098	CcSEcCtD
Asenapine—Syncope—Prednisone—systemic scleroderma	0.000598	0.00098	CcSEcCtD
Asenapine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000594	0.000974	CcSEcCtD
Asenapine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000591	0.000969	CcSEcCtD
Asenapine—Loss of consciousness—Prednisone—systemic scleroderma	0.000586	0.00096	CcSEcCtD
Asenapine—Vomiting—Lisinopril—systemic scleroderma	0.000582	0.000955	CcSEcCtD
Asenapine—Angiopathy—Methotrexate—systemic scleroderma	0.000581	0.000952	CcSEcCtD
Asenapine—Immune system disorder—Methotrexate—systemic scleroderma	0.000578	0.000947	CcSEcCtD
Asenapine—Rash—Lisinopril—systemic scleroderma	0.000578	0.000947	CcSEcCtD
Asenapine—Convulsion—Prednisone—systemic scleroderma	0.000578	0.000947	CcSEcCtD
Asenapine—Dermatitis—Lisinopril—systemic scleroderma	0.000577	0.000946	CcSEcCtD
Asenapine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000577	0.000945	CcSEcCtD
Asenapine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000576	0.000944	CcSEcCtD
Asenapine—Hypertension—Prednisone—systemic scleroderma	0.000576	0.000943	CcSEcCtD
Asenapine—Headache—Lisinopril—systemic scleroderma	0.000574	0.000941	CcSEcCtD
Asenapine—Arthralgia—Prednisone—systemic scleroderma	0.000568	0.00093	CcSEcCtD
Asenapine—Anxiety—Prednisone—systemic scleroderma	0.000566	0.000927	CcSEcCtD
Asenapine—Mental disorder—Methotrexate—systemic scleroderma	0.000561	0.000919	CcSEcCtD
Asenapine—Malnutrition—Methotrexate—systemic scleroderma	0.000557	0.000913	CcSEcCtD
Asenapine—Dysgeusia—Methotrexate—systemic scleroderma	0.000546	0.000894	CcSEcCtD
Asenapine—Nausea—Lisinopril—systemic scleroderma	0.000544	0.000892	CcSEcCtD
Asenapine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000544	0.000892	CcSEcCtD
Asenapine—Shock—Prednisone—systemic scleroderma	0.000535	0.000877	CcSEcCtD
Asenapine—Nervous system disorder—Prednisone—systemic scleroderma	0.000534	0.000875	CcSEcCtD
Asenapine—Tachycardia—Prednisone—systemic scleroderma	0.000531	0.00087	CcSEcCtD
Asenapine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000531	0.00087	CcSEcCtD
Asenapine—Anaemia—Methotrexate—systemic scleroderma	0.000515	0.000844	CcSEcCtD
Asenapine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00051	0.000836	CcSEcCtD
Asenapine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000506	0.000829	CcSEcCtD
Asenapine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000506	0.000829	CcSEcCtD
Asenapine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000503	0.000824	CcSEcCtD
Asenapine—Malaise—Methotrexate—systemic scleroderma	0.000502	0.000823	CcSEcCtD
Asenapine—Leukopenia—Methotrexate—systemic scleroderma	0.000499	0.000817	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000496	0.000812	CcSEcCtD
Asenapine—Insomnia—Prednisone—systemic scleroderma	0.000492	0.000807	CcSEcCtD
Asenapine—Convulsion—Methotrexate—systemic scleroderma	0.000483	0.000791	CcSEcCtD
Asenapine—Dyspepsia—Prednisone—systemic scleroderma	0.000479	0.000785	CcSEcCtD
Asenapine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000477	0.000781	CcSEcCtD
Asenapine—Arthralgia—Methotrexate—systemic scleroderma	0.000474	0.000777	CcSEcCtD
Asenapine—Fatigue—Prednisone—systemic scleroderma	0.000469	0.000769	CcSEcCtD
Asenapine—Constipation—Prednisone—systemic scleroderma	0.000465	0.000763	CcSEcCtD
Asenapine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000455	0.000745	CcSEcCtD
Asenapine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000446	0.000731	CcSEcCtD
Asenapine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000445	0.00073	CcSEcCtD
Asenapine—Hypotension—Methotrexate—systemic scleroderma	0.000425	0.000696	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000414	0.000679	CcSEcCtD
Asenapine—Insomnia—Methotrexate—systemic scleroderma	0.000411	0.000674	CcSEcCtD
Asenapine—Dyspnoea—Methotrexate—systemic scleroderma	0.000405	0.000664	CcSEcCtD
Asenapine—Somnolence—Methotrexate—systemic scleroderma	0.000404	0.000663	CcSEcCtD
Asenapine—Hypersensitivity—Prednisone—systemic scleroderma	0.000401	0.000657	CcSEcCtD
Asenapine—Dyspepsia—Methotrexate—systemic scleroderma	0.0004	0.000656	CcSEcCtD
Asenapine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000393	0.000643	CcSEcCtD
Asenapine—Fatigue—Methotrexate—systemic scleroderma	0.000392	0.000643	CcSEcCtD
Asenapine—Asthenia—Prednisone—systemic scleroderma	0.00039	0.00064	CcSEcCtD
Asenapine—Dizziness—Prednisone—systemic scleroderma	0.00036	0.00059	CcSEcCtD
Asenapine—Vomiting—Prednisone—systemic scleroderma	0.000346	0.000567	CcSEcCtD
Asenapine—Rash—Prednisone—systemic scleroderma	0.000343	0.000562	CcSEcCtD
Asenapine—Dermatitis—Prednisone—systemic scleroderma	0.000343	0.000562	CcSEcCtD
Asenapine—Headache—Prednisone—systemic scleroderma	0.000341	0.000559	CcSEcCtD
Asenapine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000335	0.000549	CcSEcCtD
Asenapine—Asthenia—Methotrexate—systemic scleroderma	0.000326	0.000535	CcSEcCtD
Asenapine—Nausea—Prednisone—systemic scleroderma	0.000323	0.00053	CcSEcCtD
Asenapine—Dizziness—Methotrexate—systemic scleroderma	0.000301	0.000493	CcSEcCtD
Asenapine—Vomiting—Methotrexate—systemic scleroderma	0.000289	0.000474	CcSEcCtD
Asenapine—Rash—Methotrexate—systemic scleroderma	0.000287	0.00047	CcSEcCtD
Asenapine—Dermatitis—Methotrexate—systemic scleroderma	0.000286	0.000469	CcSEcCtD
Asenapine—Headache—Methotrexate—systemic scleroderma	0.000285	0.000467	CcSEcCtD
Asenapine—Nausea—Methotrexate—systemic scleroderma	0.00027	0.000443	CcSEcCtD
